1. Academic Validation
  2. Plasminogen Activator Inhibitor 1 Controls Abdominal Aortic Aneurism Formation via the Modulation of TGF-β/Smad2/3 Signaling in Mice

Plasminogen Activator Inhibitor 1 Controls Abdominal Aortic Aneurism Formation via the Modulation of TGF-β/Smad2/3 Signaling in Mice

  • FASEB J. 2025 May 15;39(9):e70562. doi: 10.1096/fj.202403133RR.
Mantong Zhao 1 Lina Hu 2 Zhuo Lin 1 Xueling Yue 1 Xintong Zheng 1 Meiling Piao 1 Xianglan Jin 3 Limei Piao 1 Rihua Cui 1 Meilan Liu 1 Xian Wu Cheng 1 4
Affiliations

Affiliations

  • 1 Department of Cardiology and Hypertension, Jilin Provincial Key Laboratory of Stress and Cardiovascular Disease, Yanbian University Hospital, Yanji, Jilin, P.R. China.
  • 2 Department of Public Health, Guilin Medical College, Guilin, Guangxi, P.R. China.
  • 3 Department of Anesthesiology, Yanbian University Hospital, Yanji, Jilin, P.R. China.
  • 4 Department of Community Healthcare & Geriatrics, Nagoya University Graduate School of Medicine, Nagoya, Aichike, Japan.
Abstract

Given that plasminogen activator inhibitor 1 (PAI-1) plays an important role in human pathobiology and epigallocatechin-3-gallate (EGCG) exerts vasculoprotective actions, we investigated the role(s) of PAI-1 and the protective effect of EGCG in the mechanism of AAA formation, with a focus on inflammation, oxidative stress, proteolysis, and Apoptosis in vivo and in vitro. Nine-week-old wild-type mice (PAI-1+/+) and PAI-1 deficiency mice (PAI-1-/-) randomly assigned to the sham operation (0.9% saline) and AAA induction (calcium chloride) and subjected to biological and morphological analysis after four weeks. On operative day 28, the AAA lesions had decreased levels of PAI-1 mRNA and protein. As compared with AAA-PAI-1+/+ mice, PAI-1 deficiency aggravated AAA formation accompanied by plasma TNF-α and IL-1β elevations. PAI-1-/- resulted in harmful changes in the levels of gp91phox, cleaved-caspase 8, TGF-β, p-Smad2/3, Collagen I/III, gp91phox, ICAM-1, VCAM-1 mRNAs and/or protein in the AAA lesions as well as oxidative stress production and macrophage infiltration. PAI-1-/- also increased elastin degradation and Collagen accumulation associated with the reduction of proteolytic MMP-2/-9 expressions and activities. While EGCG reversed the above changes and upregulated PAI-1 expression. In vitro, PAI-1 inhibition (silencing and pharmacological inhibitor) and overexpression, respectively, increased and lowered oxidative stress-induced VSMCs Apoptosis and investigated extracellular protein turnover-related protein changes. These results suggested that the protective role of PAI-1 and EGCG in AAA formation is based on their ability to inhibit inflammation, oxidative stress, and Apoptosis. Moreover, EGCG-mediated PAI-1 induction might provide a potential pharmacological treatment for AAA.

Keywords

abdominal aortic aneurysm; apoptosis; epigallocatechin‐3‐gallate; inflammation; oxidative stress; plasminogen activator inhibitor 1.

Figures
Products